What is Cibus?
Cibus is a transformative force in the food and agriculture sector, leveraging its proprietary Rapid Trait Development System (RTDS) to redefine crop science. By utilizing advanced precision gene editing, the company develops beneficial plant traits that enhance nutritional profiles and improve crop resilience. This technological edge allows Cibus to address global food security challenges through sustainable, science-driven solutions. As a leader in the ag-tech space, the firm bridges the gap between fundamental biological research and commercial-scale agricultural application, ensuring that its innovations meet the rigorous demands of modern food production systems.
How much funding has Cibus raised?
Cibus has raised a total of $246.9M across 12 funding rounds:
Private Equity
$2.1M
Private Equity
$13.6M
Debt
$4M
Private Equity
$13.5M
Debt
$4.3M
Private Equity
$57M
Series B
$57M
Private Equity
$19.1M
Series C
$70M
Debt
$1M
Private Equity (2011): $2.1M, investors not publicly disclosed
Private Equity (2013): $13.6M, investors not publicly disclosed
Debt (2014): $4M, investors not publicly disclosed
Private Equity (2014): $13.5M, investors not publicly disclosed
Debt (2015): $4.3M, investors not publicly disclosed
Private Equity (2015): $57M, investors not publicly disclosed
Series B (2017): $57M, investors not publicly disclosed
Private Equity (2017): $19.1M, investors not publicly disclosed
Series C (2018): $70M with participation from Fidelity Management and Research Company, Alexandria Venture Investments, and Cormorant Asset Management
Debt (2020): $1M led by PPP
Key Investors in Cibus
Fidelity Management and Research Company
A global financial services powerhouse providing comprehensive investment, wealth management, and advisory solutions to institutional and individual clients.
Alexandria Venture Investments
The venture capital arm of a prominent life sciences REIT, specializing in the development and financing of innovative biotechnology and research-focused entities.
Cormorant Asset Management
A specialized life sciences investment firm that applies fundamental scientific principles to support high-growth companies within the biotech and allied sectors.
What's next for Cibus?
With a robust capital structure now in place, Cibus is poised to accelerate the commercialization of its RTDS-derived product pipeline. The company's strategic roadmap focuses on scaling its gene-editing platform to address broader market needs, including climate-resilient crops and enhanced nutritional outputs. By leveraging its recent financing, Cibus is well-positioned to deepen its research and development capabilities, expand its intellectual property portfolio, and solidify its market dominance. Future growth will likely be driven by strategic partnerships and the continued deployment of its precision breeding technologies to meet the increasing global demand for sustainable and high-quality agricultural products.
See full Cibus company page
